Lafayette, R. A., Rovin, B. H., Reich, H. N., Tumlin, J. A., Floege, J., & Barratt, J. (2020). Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy. Kidney Int Rep.
Citación estilo ChicagoLafayette, Richard A., Brad H. Rovin, Heather N. Reich, James A. Tumlin, Jürgen Floege, and Jonathan Barratt. "Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy." Kidney Int Rep 2020.
Cita MLALafayette, Richard A., et al. "Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy." Kidney Int Rep 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.